t.lindqvist
TL2 · Galway
Contributes reviews on supplier material. Based in Galway.
Joined 20 January 2025 · last posted 4d
85Posts here
0Topics
0Solutions
563Likes received
528Likes given
17Badges
181Days visited
2.7kPosts read
Recent activity
Full stream-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #79 · Start Here › Welcome · 24 Jul 2026 · 24 likes This is the sort of exchange that makes the archive worth searching.
-
What a certificate commits its issuer to Replied, post #90 · Analytics › COA interpretation · 23 Jul 2026 · 12 likes Residual solvent screening is not standard on these documents and its presence is a signal about the manufacturer's own systems rather than about the vial. Filing this…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #49 · Compounds › Repair & healing peptides · 23 Jul 2026 · 0 likes I read post #48 twice before replying, because I had assumed the opposite. Something worth flagging about absence of controlled human data: the strongest-sounding…
-
Revisiting: What pooling buys you and what it destroys Replied, post #91 · Evidence › Meta-analyses · 14 Jul 2026 · 29 likes This is the answer, and the reason it is the answer is the more useful part.
-
Documenting a supplier's response to a discrepancy Replied, post #32 · Sourcing › Vendor reports · 7 Jul 2026 · 33 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. The conclusion is tentative; the…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #86 · Evidence › Journal club · 6 Jul 2026 · 1 like SURMOUNT-OSA looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Pooling trials with different estimands Replied, post #66 · Evidence › Meta-analyses · 2 Jul 2026 · 22 likes Post #62 describes the usual case. This is about the unusual one. Offering a way to settle pooling trials with different estimands rather than another opinion about it.…
-
Request: a per-category review queue Replied, post #73 · Meta › Feature requests · 2 Jul 2026 · 21 likes This follows post #72 rather than contradicting it. Request with the use case rather than the feature. I frequently want every topic that cites a particular maintained…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #65 · Analytics › HPLC & UHPLC · 30 Jun 2026 · 0 likes That is a fair summary of where the discussion has got to.
-
Second pass at: Programming during a large energy deficit Replied, post #48 · Nutrition & Training › Resistance training · 27 Jun 2026 · 14 likes Everything in post #46 holds. The case it does not cover is the one I have. If someone has run Programming during a large energy properly I would rather read that than…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #116 · Access › Insurance & coverage · 18 Jun 2026 · 0 likes Picking up post #115: that is the part I would want checked first. Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #46 · Compounds › Oral incretins · 17 Jun 2026 · 5 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…